ALLR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
ALLR is not a good buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock is trading weakly around $1.47, has no supportive news or insider/hedge fund accumulation, and the latest quarter shows worsening losses despite flat revenue. While the technical trend is short-term bullish, the lack of strong fundamental improvement, absence of positive catalysts, and no strong proprietary buy signal make this a poor long-term entry today.
ALLR shows a short-term bullish structure with MACD histogram positive and expanding, and moving averages aligned bullishly (SMA_5 > SMA_20 > SMA_200). RSI_6 at 73.461 is elevated and near overbought territory, so momentum is strong but stretched. Price at 1.47 is above pivot support at 1.398 and below resistance at 1.528, meaning upside exists but the stock is not yet showing a compelling risk-reward entry for a long-term buyer. The stock trend model suggests modest near-term gains, but not enough to outweigh the weak fundamentals.
No news in the recent week. Technical momentum is constructive with bullish moving averages and positive MACD. The stock is holding above its pivot level, and the short-term pattern analysis suggests a mild probability of upside over the next week.
No valuation data is available, and there is no AI Stock Picker or SwingMax buy signal today.
In Q4 2025, Allarity Therapeutics reported revenue of 320,000, which was flat year over year. Net income deteriorated to -3,373,000, down 54.74% YoY, and EPS fell to -0.21, down 87.79% YoY. Gross margin remained at 100, but the overall earnings trend is negative and does not support a strong long-term buy case.
No analyst rating or price target change data was provided. Based on the available information, Wall Street sentiment appears neutral to cautious: there is no evidence of recent bullish upgrades, no positive target revisions, no meaningful insider or hedge fund accumulation, and no event-driven catalyst to support a higher valuation.
